Study Summary
This trial is testing whether a drug called rapamycin can treat vitiligo. People will apply it to one side of their body and a placebo to the other to see if there's a difference. The study will also see if patients are happy with the treatment and if there are any side effects.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 1 Secondary · Reporting Duration: 6 months
6 months
Average score of Dermatology Quality of Life questionnaire (or Teenager Quality of Life Index)
Number of lesions with no response
Number of lesions with partial response
Numbers of lesions with complete response
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Side Effects for
CNI Group
14%pneumonia
14%acute kidney failure
Trial Design
3 Treatment Groups
Topical rapamycin 0.1%
1 of 3
Topical rapamycin 0.001%
1 of 3
Placebo
1 of 3
Active Control
Experimental Treatment
Non-Treatment Group
20 Total Participants · 3 Treatment Groups
Primary Treatment: Rapamycin · Has Placebo Group · Phase 2
Topical rapamycin 0.001%
Drug
Experimental Group · 1 Intervention: Rapamycin · Intervention Types: DrugPlacebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DrugTopical rapamycin 0.1%
Drug
ActiveComparator Group · 1 Intervention: Rapamycin · Intervention Types: DrugTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rapamycin
2008
Completed Phase 4
~1200
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
837 Previous Clinical Trials
5,378,570 Total Patients Enrolled
1 Trials studying Vitiligo
4 Patients Enrolled for Vitiligo
American Skin AssociationOTHER
2 Previous Clinical Trials
42 Total Patients Enrolled
1 Trials studying Vitiligo
12 Patients Enrolled for Vitiligo
Ahmad Aleisa, MDPrincipal InvestigatorMedical University of South Carolina
Eligibility Criteria
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have nonsegmental vitiligo.
Who else is applying?
What state do they live in?
| Nevada | 33.3% |
| Arizona | 16.7% |
| New Jersey | 16.7% |
| Other | 33.3% |
How old are they?
| 18 - 65 | 66.7% |
| < 18 | 33.3% |
What site did they apply to?
| Medical University of South Carolina | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 33.3% |
| Met criteria | 66.7% |
How responsive is this trial?
Typically responds via
| 100.0% | |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments